+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)


World Veterinary/Animal Vaccines Market - Opportunities and Forecasts, 2017 - 2023

  • ID: 3772963
  • Report
  • September 2019
  • Region: Global
  • Allied Analytics LLP
Veterinary/animal vaccines are injected to animals to improve health conditions, increase production of livestock in economical way and prevent transmission of infectious diseases. These vaccines provide immunity against bacterial, viral, protozoal, and multicellular pathogens. Consequently, it prevents death of animals, loss of milk & meat, and economic losses of owners. It also helps in prevention of animal to human transmission of infectious diseases.

Increase in livestock and instances of disease and incidence of zoonotic diseases drive growth of the world veterinary/animal vaccines market. In addition, emergence of new types of vaccines supplements the growth. Rising maintenance costs for storage of vaccines and increasing prices of meat are hindering the growth of the market. Technological advancements such as DNA vaccines and awareness of animal health in emerging economies would present tremendous opportunities.

The world veterinary/animal vaccines market is segmented based on product, diseases, technology, and regions. The product segment is further classified into livestock, companion, poultry, equine, and porcine. On the basis of diseases, the market is further categorized into rabies, distemper, foot and mouth, gumboro, swine and avian influenza, and strangles. Technologies covered in the report include live attenuated, DNA, and inactivated. The market is divided based on geography into North America, Europe, Asia, and Latin America, Middle East and Africa (LAMEA).

The prominent manufacturers operating in the market are Bayer Healthcare, Bioniche Animal Health, Boehringer Ingelheim, Ceva Animal Health, Elanco Animal Health, Heska Corporation, Merck Animal Healthcare, Zoetis, Merial Inc., and Virbac. Agreements, approvals, mergers & acquisitions, partnerships, joint ventures, collaborations, expansions, and others are some of the key strategies adopted by these companies to strengthen their position in the market.


The report offers a detailed analysis of key driving and restraining factors of the world veterinary/animal vaccines market.
This report offers an in-depth quantitative analysis of the current market and estimations through 2015 and 2020, which assists in identifying the prevailing market opportunities.
An exhaustive analysis of key strategies adopted by leading manufacturers helps in understanding competitive scenario.
The report provides an extensive analysis of current and future market status of the world veterinary/animal vaccines market.
Comprehensive analysis has been done in this report by constructing market estimations for the key market segments between 2015 and 2020.
An extensive analysis of current research and clinical developments withinthe world veterinary/animal vaccines market is provided with key market dynamic factors that help in understanding the behavior of the market.
The world veterinary/animal vaccines market is segmented into North America, Asia, Europe, and Latin America, Middle East and Africa (LAMEA).


By Product


By Technology


By Disease

Foot and Mouth
Swine and Avian Influenza

By Geography

North America
Latin America, Middle East and Africa (LAMEA)


Bayer Healthcare
Bioniche Animal Health
Boehringer Ingelheim
Ceva Animal Health
Elanco Animal Health
Heska Corporation
Merck Animal Healthcare
Merial Inc.

Note: Product cover images may vary from those shown

The analyst offers exhaustive research and analysis based on a wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics, and regional intelligence. The in-house industry experts play an instrumental role in designing analytic tools and models, tailored to the requirements of a particular industry segment. The primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks, and face-to-face interactions.

They are also in professional corporate relations with various companies that allow them greater flexibility for reaching out to industry participants and commentators for interviews and discussions.

They also refer to a broad array of industry sources for their secondary research, which typically include; however, not limited to:

  • Company SEC filings, annual reports, company websites, broker & financial reports, and investor presentations for competitive scenario and shape of the industry
  • Scientific and technical writings for product information and related preemptions
  • Regional government and statistical databases for macro analysis
  • Authentic news articles and other related releases for market evaluation
  • Internal and external proprietary databases, key market indicators, and relevant press releases for market estimates and forecast

Furthermore, the accuracy of the data will be analyzed and validated by conducting additional primaries with various industry experts and KOLs. They also provide robust post-sales support to clients.